Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma
Author:
Affiliation:
1. Cell and Molecular Biology Program, Department of Clinical Sciences; Colorado State University; Fort Collins CO USA
2. Flint Animal Cancer Center, Veterinary Medical Center; Colorado State University; Fort Collins CO USA
Publisher
Wiley
Subject
General Veterinary
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/vco.12044/fullpdf
Reference54 articles.
1. New drugs in melanoma: it's a whole new world;Eggermont;European Journal of Cancer,2011
2. Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events;Weber;Oncologist,2007
3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;New England Journal of Medicine,2011
4. Vemurafenib: targeted inhibition of mutated BRAF for treatment of advanced melanoma and its potential in other malignancies;Sharma;Drugs,2012
5. The role of BRAF V600 mutation in melanoma;Ascierto;Journal of Translational Medicine,2012
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet Dogs;Clinical Cancer Research;2024-07-09
2. Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogs;2024-02-14
3. Cross-Species Comparison of the Pan-RAF Inhibitor LY3009120’s Anti-Tumor Effects in Equine, Canine, and Human Malignant Melanoma Cell Lines;Genes;2024-02-03
4. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer;Veterinary Pathology;2023-10-31
5. Comparative oncology: overcoming human cancer through companion animal studies;Experimental & Molecular Medicine;2023-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3